Circulars issued regarding Field Safety Corrective Action and Voluntary Recalls of certain products batches
31 Jul 2024
Reference: CIR-2024-00000134
To all Health facilities and healthcare practitioners in Dubai's private health sector
Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the MOHAP for perusal and adherence to what is stated
Circular No.6111 for the year 2024 regarding notifications of Field Safety Corrective Action
Circular No.5921 for the year 2024 regarding Voluntary Recall of One lot of Pharmaceutical Product Budesonide Inhalation Suspension 0.5mg/2ml
Circular No.5950 for the year 2024 Voluntary Recall of One Batch of Voluntary Recall of Olfast Granules
Circular No.5923 for the year 2024 regarding Recall of Pharmaceutical Product Lot Rezzayo 200mg Vial
Circular No.5922 for the year 2024 Voluntary Recall of one batch of pharmaceutical product Septanest SP
Thanks in advance for your good co-operation
Drug Control Section
Health Regulation Sector
DHA
Supporting Documents:
downloadDo you find this Content helpful?
Wassel SotakSend Feedback